Since the introduction of the SmartCycler® System in 2000, Cepheid has been at the forefront of Molecular Diagnostics innovation. In 2006, Cepheid introduced an even better way for any healthcare facility to leverage the power of molecular diagnostics. Since then, on-demand accuracy, speed, and ease-of-use have become synonymous with the platform and associated tests. Today, with over 11,000 systems worldwide, Cepheid innovation is rapidly expanding access to a technology once reserved for only the most sophisticated of laboratories. And, driving new market opportunities that enhance the health of our communities, improve patient outcomes, and save lives around the world. We know that each test can make a difference and, together, we will continue to deliver even more innovative new products that will empower us all to make better healthcare decisions. It's our vision for a better way.
Healthcare associated infections in hospitals represent a significant cause of morbidity and mortality. Recent reports estimate hospital stays for MRSA infection have more than tripled since 2000 and represent nearly 20 billion in excess healthcare costs each year. Management and prevention of HAI is a shared responsibility that includes the healthcare industry.